ARTERITIS FOLLOWING INTRAARTERIAL CHEMOTHERAPY FOR LIVER-TUMORS

Citation
L. Belli et al., ARTERITIS FOLLOWING INTRAARTERIAL CHEMOTHERAPY FOR LIVER-TUMORS, European radiology, 7(3), 1997, pp. 323-326
Citations number
25
Categorie Soggetti
Radiology,Nuclear Medicine & Medical Imaging
Journal title
ISSN journal
09387994
Volume
7
Issue
3
Year of publication
1997
Pages
323 - 326
Database
ISI
SICI code
0938-7994(1997)7:3<323:AFICFL>2.0.ZU;2-R
Abstract
Primary and metastatic tumors of the liver can be treated successfully with transcatheter chemoembolization (TACE) during selective arterial catheterism. Arteritis is a possible referred side effect which can l ead to tortuosity of the arteries, stenosis and occlusion of vessels. In our hospitals 117 consecutive patients were treated with TACE from January 1990 to December 1992; 61 patients were affected by hepatocell ular carcinoma (HCC) and 56 were affected by metastases from colorecta l carcinoma. Each patient received from 1 to 4 treatments at monthly i ntervals using epirubicin/Lipiodol ultrafluid (E/LUF) or a mixture of epirubicin and mitomicin C (MC)/LUF and followed by gelatine sponge in jection in the hepatic artery. Selective angiography performed 30-62 d ays after the first chemoembolization showed artery stenosis in 7 pati ents and thrombosis in 2 cases related to toxic arteritis due to chemo embolization. Reports about arteritis during TACE treatments are discu ssed.